Coming Soon...

NNH Interactive · Provider Clinical Tool

ANCA Vasculitis
Reduced-Dose Prednisone Taper PEXIVAS-Based Clinical Taper Generator

Generates a patient-specific, weight-based reduced-dose glucocorticoid taper with actual calendar dates, Athena-ready instructions, and optimized prednisone prescriptions — updated instantly as you type.

Why reduced-dose?

PEXIVAS randomized 704 patients with severe GPA/MPA to a reduced-dose vs. standard glucocorticoid regimen, cutting cumulative exposure ~40% over the first 6 months.

Fewer infections

Serious infections at 1 year were significantly lower with the reduced-dose regimen (27.2% vs 33.0%) — the major driver of early treatment-related harm.

Similar efficacy

Reduced-dose was noninferior to standard dosing for the composite of death or ESKD, with comparable remission and relapse outcomes.

Intended population

New-onset or relapsing severe ANCA-associated vasculitis (GPA/MPA) on induction therapy; UpToDate authors also consider it reasonable for EGPA. May begin immediately or after IV pulse glucocorticoids.

Walsh M, Merkel PA, Peh CA, et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med. 2020;382:622–631.

The taper displayed here follows the reduced-dose glucocorticoid regimen from PEXIVAS as reproduced by UpToDate with permission (Graphic 129362, v4.0).

For NNH clinical staff only. Clinical decision support, not a substitute for clinical judgment. Verify dosing, halt the taper for evidence of relapse, and individualize for relapse history and concomitant therapy.

Developed by Craig G. Hurwitz, MD · Northern Nephrology & Hypertension

Patient Inputs

Enter weight and the prednisone start date — everything below updates instantly.

Less than 50 kgstarts at 50 mg
50 to 75 kgstarts at 60 mg
Greater than 75 kgstarts at 75 mg

Week 1 begins on the start date; each taper week runs 7 days and leap years are handled automatically. All patients reach 5 mg daily by week 22; the physician then selects how long to continue 5 mg. The default 4-week continuation completes a 6-month (26-week) course; PEXIVAS itself continued 5 mg through week 52.
Starting dose enter weight Week 1 begins: —

PEXIVAS Dose Timeline

Each segment is one published taper step. Hover, tap, or use arrow keys for dose, dates, and running cumulative exposure. Darker segments = higher dose.

Calendar Schedule

The full taper as actual calendar dates. Consecutive weeks at the same dose are combined into a single interval.

Athena Patient Instructions

Ready to paste directly into the Athena patient instructions field. Pick a format, then copy.

Prescription Optimization Engine

Minimum pill burden using 20 mg, 10 mg, and 5 mg tablets. Half-tablets are used only where a dose ends in 2.5 mg; 1 mg tablets are added only if the schedule requires a 6 mg dose.

Prescription Preview

Exactly what would be prescribed, one entry per tablet strength.

Printable Patient Calendar

A clean, checkbox schedule the patient can keep on the fridge and mark at each dose change.

Published PEXIVAS Dose Table

The regimen as published — all three weight columns, with your patient's column highlighted. Expand any row for dates and tablet breakdown. The final row shows the published week-52 course; your patient's schedule ends at the week selected above.

Clinical Pearls

Evidence and practical guidance for running a reduced-dose taper safely.

Glucocorticoid Safety Checklist

Work through these at taper initiation. Checks persist while this page stays open.

0 of 8

Cumulative Steroid Exposure

High burden early, rapid de-escalation, then a long low-dose plateau. Hover or tap the chart for week-by-week totals.

Taper Summary

The one-glance version for your note.

References

  1. Walsh M, Merkel PA, Peh CA, et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med. 2020;382:622–631. doi:10.1056/NEJMoa1803537
  2. The taper schedule displayed on this page follows the reduced-dose glucocorticoid tapering regimen for ANCA-associated vasculitis reproduced by UpToDate from the original PEXIVAS publication with permission (UpToDate Graphic 129362, Version 4.0; © 2020 Massachusetts Medical Society).

Main Office

Northern Nephrology & Hypertension
52 Tom Miller Road
Plattsburgh, NY 12901
Phone: (518) 324-4000
Fax: (518) 324-4001

Office Hours: Mon-Fri 9AM-5PM

© 2026 Craig G. Hurwitz, MD — Northern Nephrology & Hypertension